(Q58415992)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

L Karlin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

B Arnulf

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

L Ades

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Robin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

R P De Latour

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Malphettes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

N Kabbara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

B Asli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

V Rocha

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

J P Fermand

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

G Socie

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

19 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

250-256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2010.90

31 January 2020

exact match

0 references

cites work

Advances in biology of multiple myeloma: clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

Allogeneic transplantation for multiple myeloma: further evidence for a GVHD-associated graft-versus-myeloma effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

A comparison of allografting with autografting for newly diagnosed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

Follow‐up of patients with progressive multiple myeloma undergoing allografts after reduced‐intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

International uniform response criteria for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

Clinical outcomes in t(4;14) multiple myeloma: a chemotherapy-sensitive disease characterized by rapid relapse and alkylating agent resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

Donor leukocyte infusions for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

7 January 2021

Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

7 January 2021

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

7 January 2021

The central role of the propensity score in observational studies for causal effects

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

7 January 2021

Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

7 January 2021

The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

7 January 2021

Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

7 January 2021

Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.90

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20400980%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference